Australian Research Gives Hope to Patients with Rare Blood Cancers
Myelofibrosis is a rare and dangerous blood cancer, and Australian researchers claim to have discovered a new, highly targeted method of treating it, boosting expectations for more potent therapies that go beyond symptom management. Researchers from the University of Adelaide, SA Pathology, and the South Australian Health and Medical Research Institute have developed an immunotherapy-based strategy that targets the aberrant blood cells causing the illness specifically.

